Immunotherapy for lung cancer Doctors Abroad — Page 2

Associate Professor Hasan Mutlu is a specialist medical oncologist at Medical Park Antalya who focuses on targeted cancer therapies and next-generation genetic research.

• Specialises in precise immunotherapy protocols for non-small cell and small cell lung cancers
• Experienced in next-generation genetic research to identify specific tumour markers
• Trained at Akdeniz University – a major Turkish centre for internal medicine research
• Expert in combining targeted chemotherapy with modern immunotherapy agents
• Focuses on organ-specific tumours and complementary medicine approaches

Professor Mustafa Serkan Alemdar is a specialist medical oncologist at Medical Park Antalya Hospital Complex with deep expertise in internal medicine and oncology. He oversees advanced cancer treatments at one of Turkey's largest medical facilities.

• Specialises in medical oncology at Akdeniz University – a leading research hospital
• Trained in internal medicine to manage complex comorbidities in cancer patients
• Expertise in administering targeted therapies and modern immunotherapy protocols
• Focuses on evidence-based treatment plans for various lung cancer stages

Associate Professor Muhammed Mustafa Atci is a lead medical oncologist at Istinye University Liv Hospital Topkapi and an Education Coordinator for oncology specialists.

• Specialises in non-small cell lung cancer and metastatic cases
• Published research on how body mass index and age impact lung cancer treatment outcomes
• Member of the American Society of Clinical Oncology (ASCO)
• Focuses on tailoring therapy based on clinical and pathological characteristics

Professor Ercan Ozden is a medical oncology specialist at VM Medical Park Pendik who focus on targeted cancer therapies. He completed his internal medicine training at Istanbul University Cerrahpasa Faculty of Medicine.

• Specialises in medical oncology and subspecialty internal medicine
• Expertise in managing systemic treatments for thoracic malignancies
• Graduated from the prestigious English Medical Programme at Istanbul University
• Practises at VM Medical Park – a major Turkish hospital group known for oncology

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Associate Professor Atakan Topcu is a leading medical oncologist who combines targeted immunotherapy with a specialised focus on lung cancer patient recovery and well-being.

• Serves on the editorial board of BMC Cancer, a prestigious international peer-reviewed medical journal
• Specialises in managing immunotherapy side effects and cancer-related malnutrition in lung cancer cases
• Completed a clinical observership at the University of Leicester in the United Kingdom
• Published over 50 scientific articles focusing on solid tumours and immunotherapy outcomes
• Member of the European Society for Medical Oncology (ESMO)

Associate Professor Ayse Irem Yasin is an ESMO-certified oncologist who manages complex lung cancer cases at Medipol Acibadem District Hospital.

• Holds European Society for Medical Oncology (ESMO) board certification
• Completed clinical observerships at Cleveland Clinic and Harvard Medical School
• Specialises in treating lung adenocarcinomas and malignant melanomas
• Former specialist at Şişli Etfal Training and Research Hospital
• Focuses on targeted immunotherapy protocols for solid tumours

Professor Raj Nagarkar has performed over 50,000 cancer surgeries and leads clinical research as the Chairperson of HCG Manavata Cancer Centre.

• Trained in surgical oncology at the prestigious Tata Memorial Hospital in Mumbai
• Completed advanced surgical training at the Royal College of Surgeons, Edinburgh
• Managed more than 200 clinical trials focusing on emerging cancer therapies
• Specialises in thoracic oncology with a focus on lung and breast cancers
• Serves as a Professor for the Delhi National Board of Examinations

Dr Shaunak Valame focuses on the molecular basis of cancer and specialises in targeted therapies at HCG Manavata Cancer Centre.

• Presented research on gastrointestinal cancer at the American Society of Clinical Oncology symposium in San Francisco
• Completed specialist medical oncology training at the prestigious Indraprastha Apollo Hospital in New Delhi
• Served as a senior resident and registrar in dedicated cancer research and treatment centres
• Experienced in administering the latest targeted therapies and immunotherapy protocols
• Regularly lectures for international oncology programmes on emerging cancer treatments